Why is CanSino Biologics, Inc. ?
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -60.98
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -15.35%, its profits have risen by 80%
- Along with generating -15.35% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CanSino Biologics, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at HKD -215.37 MM
Highest at 0.57%
Highest at 11.17 %
Highest at HKD 50.47 MM
Highest at HKD 50.34 MM
Fallen by -244.82% (YoY
Highest at HKD 750.25 MM
Highest at HKD 83.8 MM
Highest at HKD 0.18
Lowest at HKD 2,945.14 MM
Here's what is working for CanSino Biologics, Inc.
Operating Profit to Sales
Pre-Tax Profit (HKD MM)
Pre-Tax Profit (HKD MM)
Net Profit (HKD MM)
Net Profit (HKD MM)
Operating Cash Flows (HKD MM)
Net Sales (HKD MM)
Net Sales (HKD MM)
Operating Profit (HKD MM)
EPS (HKD)
Raw Material Cost as a percentage of Sales
Depreciation (HKD MM)
Here's what is not working for CanSino Biologics, Inc.
Cash and Cash Equivalents
Non Operating income






